Table 1 The mean score of the patients’ symptoms (placebo and ZM group), before and after the intervention based on the SNOT-22 questionnaire
From: Interleukin-4 can play a role in allergic rhinitis patient during treatment with Zataria multiflora
Symptoms | Groups | Before intervention mean ± SD | After intervention mean ± SD | P value |
|---|---|---|---|---|
Nose | ZM | 37 ± 3.6 | 19 ± 1.2 | < 0.0001 |
Placebo | 43 ± 4.4 | 41 ± 3.4 | ||
Ear | ZM | 3.1 ± 0.2 | 2.9 ± 0.1 | 0.78 |
Placebo | 3.1 ± 0.5 | 2.9 ± 0.3 | ||
Sleep state | ZM | 9 ± 0.65 | 2.5 ± 1.4 | < 0.0001 |
Placebo | 9.2 ± 0.86 | 8.7 ± 0.8 | ||
Activity | ZM | 8.8 ± 3.1 | 4.1 ± 1.1 | 0.47 |
Placebo | 8.1 ± 2.3 | 4.3 ± 1.5 | ||
Psychology | ZM | 7.3 ± 1.6 | 6.4 ± 3.1 | 0.9 |
Placebo | 8.1 ± 1.1 | 6.9 ± 3.4 |